A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical trial NCT00391729 · COMPLETED

Trial details

NCT number: NCT00391729
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder

Start date: 2006-10-01
Primary completion: 2007-06-01
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.